Pharmacogenomics

Papers
(The H4-Index of Pharmacogenomics is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Effects of SLCO1B1 on Elimination and Toxicities of High-Dose Methotrexate in Pediatric Acute Lymphoblastic Leukemia32
Association of OPRK1 rs963549 and rs997917 Polymorphisms With Opioid Use Disorder and Related Phenotypes23
Implication of KDM6A in Bladder Cancer23
Pharmacogenomics of Medications Given Via Nonconventional Administration Routes: A Scoping Review21
HLA Pharmacogenetic Markers of Drug Hypersensitivity from the Perspective of the Populations of the Greater Middle East20
Genotype-guided prescribing predictors in CYP2C19 intermediate metabolizers receiving percutaneous coronary intervention20
Knowledge and Attitudes of Incoming Pharmacy Students Toward Pharmacogenomics and Survey Reliability19
The Sixth European Society of Pharmacogenomics and Personalised Therapy Congress19
Highlights of 2022 and Looking Forward to 2023 at Pharmacogenomics18
Association of IL4RA Polymorphism in Predicting Susceptibility Toward Chronic Obstructive Pulmonary Disease16
Pilot Study of Multi-Gene Pharmacogenetic Testing for Pain Management in Oncology Palliative Medicine15
Update on the PriME-PGx initiative: evolution of pharmacogenetics in daily clinical practice14
Correlation of ACE insertion/deletion gene polymorphism with captopril effectiveness in Indonesian hypertensive patients14
Estimated clinical utility of multi-gene pharmacogenetic testing in a retrospective cohort of gynecology patients14
0.045233964920044